lung carcinoma
Current role of surgery in small cell lung carcinoma
... cell lung carcinoma represents 15–20% of lung ...Cell Lung Cancer (SCLC) since radiotherapy and chemoradiotherapy were found to be more efficient in the management of these ...Cell Lung ...
6
Chemotherapy for Large Cell Neuroendocrine Carcinoma of the Lung: Should It Be Treated with the Same Strategy as Small Cell Lung Carcinoma?
... Neuroendocrine Carcinoma of the Lung: Should It Be Treated with the Same Strategy as Small Cell Lung Carcinoma?, Lung Diseases - Selected State of the Art Reviews, ...
11
EVALUATION OF SELENIUM NANOPARTICLES AS A POTENTIAL CHEMOPREVENTIVE AGENT AGAINST LUNG CARCINOMA
... impact lung cancer risks. We employed an animal model of lung carcinoma that is induced by oxidative damage via Fe-NTA to examine Se-NPs synthesized by bacteria as cancer protective ...
9
Snail promotes an invasive phenotype in lung carcinoma
... In addition to being important in EMT and tumor invasion, snail also plays a role in embryonic develop- ment and it also influences apoptosis, angiogenesis and MMP9 expression, factors which are all important in tumor ...
10
Large Solitary Pulmonary Cryptococcoma Mimicking Lung Carcinoma in an Immunocompetent Patient
... A 32-year-old male chronic smoker (16 cigarettes per day; 8 pack years) presented with long standing non-productive cough with streaky hemoptysis and low grade fever for the preceding 4 months, associated with ...
5
Decreased lung carcinoma cell density on select polymer nanometer surface features for lung replacement therapies
... of lung carcinoma epithelial cells adherent to the PLGA surfaces with RMS values of ...fewer lung carcinoma cells adhered to PLGA surfaces with an RMS value of ...
7
EVALUATION OF CA125 AS MARKER IN PATIENTS WITH LUNG CARCINOMA
... with lung cancer . They also suggested that in lung carcinoma patients CA 125 can be used as a supplemental ...the lung cancer diagnosis and prognosis such as CA ...human lung cancer ...
7
Non-small-cell lung carcinoma: role of the Notch signaling pathway
... Abstract: Notch signaling plays a pivotal role during embryogenesis. It regulates three fundamental processes: lateral inhibition, boundary formation, and lineage specification. During post-natal life, Notch receptors ...
11
Combined small-cell lung carcinoma
... Abstract: Currently, studies assessing combined small-cell lung carcinoma (C-SCLC) are relatively scarce and limited. Indeed the clinicopathological features, treatment, and prognosis of patients with ...
7
Favorable Response of Advanced Superior Sulcus Non-Small Cell Lung Carcinoma to Gefitinib for 11 years complicated by Interval Development of Small Cell Carcinoma of the Lung.
... cell lung cancer who had failed ...of lung cancer, EGFR gene mutations occur in about 10% of NSCLC tumors, as assessed by the National Cancer ...cell lung cancer (NSCLC) whose tumors contain specific ...
10
Clinical potential of necitumumab in non-small cell lung carcinoma
... Under normal conditions, when EGFR interacts with its ligand, the epidermal growth factor, the former undergoes dimerization and subsequent phosphorylation, leading to the activation of downstream signaling pathways that ...
11
IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib
... erlotinib-resistant lung cancer cells more amenable to EGFR inhibition or ...mutant lung cancer cells is able to significantly decrease the percentage of ALDH positive cells and to reduce the expression of ...
14
Analysis of gene expression changes associated with human carcinoma-associated fibroblasts in non-small cell lung carcinoma
... cell growth in NSCLC [31] and other types of human lung cancers [32]. Therefore, TGFBI may be a tumor sup- pressor for NSCLC. Besides, Muraoka et al. [33] proved that blocking TGFBI expression enhanced inhibition ...
8
Pulmonary Langerhans Cell Histiocytosis Imitating Metastatic Lung Carcinoma
... nary carcinoma, from the patient’s admittance to the clinic until the thoracosopic ...left lung lower lobe bronchus contiguity in the PET-CT examination (SUVmax: ...
5
Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma
... non-small-cell lung cancer (NSCLC) have expanded dramatically in the last 10 years with the discovery of newer drugs and targeted ...cell lung cancer in the frontline ...
7
Diagnostic Value of KRAS Mutation in Non-small Cell Lung Carcinoma
... practice”, sanger capillary sequencing produced weak PCR products and only produced peaks that were observable below the detection level. In this study this method did not identify any of the KRAS mutations of any allele ...
15
Docetaxel in the treatment of non-small cell lung carcinoma: an update and analysis
... Docetaxel was first approved by the US Food and Drug Administration (FDA) in 1996 for use in metastatic breast cancer, but shortly thereafter garnered indications for first and second-line use in NSCLC. Below we review ...
14
Personalized medicine and treatment approaches in non-small-cell lung carcinoma
... strated that cisplatin/pemetrexed was non-inferior to the cis- platin/gemcitabine arm in the general patient population, with a median survival of 10.3 months in both arms. However, this predetermined subset analysis ...
11
Pituitary Metastasis in Squamous Cell Lung Carcinoma
... a lung squamous cell carcinoma with asymptomatic pituitary metastasis is ...the lung mass; multiple mediastinal lymphadenopathies; liver and diffuse bone lesions along the left side of the pituitary ...
5
Cetuximab and biomarkers in non-small-cell lung carcinoma
... non-small-cell lung cancer (NSCLC), as in several other cancer types, the epidermal growth factor receptor (EGFR) and its downstream signaling components represent a key axis that has been found not only to ...
11